BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...
Bright Minds Biosciences (DRUG) stock jumps as lead drug BMB-101 succeeds in a mid-stage trial against a severe neurological ...
Stocktwits on MSN
Why did DRUG stock rocket 51% today?
The trial had 24 patients, exceeding the original target of 20, and included a 4-week baseline. ・In the Absence cohort, patients experienced a median 73.1% reduction in seizures. ・The DEE cohort saw a ...
The Zika virus epidemic that began in Brazil in 2015 and quickly spread to other countries caused an unprecedented flood of ...
Hit a new 52-Week High of $16.56. AGF last week announced the final December 2025 cash distributions and annual 2025 ...
Migraines affect millions in the UK, yet are often misunderstood and underestimated. From throbbing pain and nausea to ...
Donald Trump said the US would “run” Venezuela until a transition of power takes place after American forces captured ...
If you’re watching the person you love struggle to survive an illness, things aren’t going to be the same — for better or for ...
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...
About SHINE Technologies, LLC Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, ...
Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback